Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-03-08

Clinical Trial Update: A 16 Week Study of HRS-7535 in Adults With Type 2 Diabetes Mellitus [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial update for HRS-7535 in adults with Type 2 Diabetes Mellitus is underway, with status currently unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • HRS-7535 (HRS-7535)

Snippet

Sponsor: Shandong Suncadia Medicine Co., Ltd. | Conditions: Type 2 Diabetes | Phase 2 | Status: UNKNOWN